Towards More Accessible and More Inclusive PrEP to Break the Cycle of HIV in France.

IF 4.9 1区 医学 Q2 IMMUNOLOGY
Jade Ghosn, Marie-Laure Chaix
{"title":"Towards More Accessible and More Inclusive PrEP to Break the Cycle of HIV in France.","authors":"Jade Ghosn, Marie-Laure Chaix","doi":"10.1002/jia2.70118","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Pre-exposure prophylaxis (PrEP) represents a major advance in HIV prevention, but its rollout in France remains limited, particularly among women, migrants and socially vulnerable populations. Despite full reimbursement by the national health system, oral PrEP is still rarely prescribed outside hospital settings, hindered by organizational constraints, inaccurate medical perceptions and persistent access inequalities. In this paper, we discuss the current limits of PrEP implementation in France, identify structural and individual barriers to its uptake and highlight possible strategies to make HIV prevention more accessible for all vulnerable populations across the country.</p><p><strong>Discussion: </strong>The goal of eliminating HIV transmission by 2030 in France continues to be jeopardized by insufficient PrEP coverage. The current prevention model remains overly hospital-centred and primarily focused on a group of men who have sex with men (MSM), which limits its broader impact. In addition to structural barriers, the insufficient diversity of prescribers and the lack of inclusive communication continue to reinforce inequalities in access. The arrival of long-acting injectable PrEP offers an important opportunity to ensure greater discretion and better adherence. However, its success will depend on expanding the range of authorized prescribers to include gynaecologists, general practitioners and family planning clinics, supported by specific training and outreach consultations. Equally critical is strengthening public awareness campaigns and extending them beyond MSM and urban centres such as Paris, to reach diverse populations across the country. Durable improvements in PrEP uptake and retention also depend on close collaboration with community-based organizations, building trust with marginalized populations and participatory approaches that actively listen to individuals' concerns and lived experiences.</p><p><strong>Conclusions: </strong>France, which is lagging behind its objective of ending the HIV epidemic, has the opportunity to rethink its prevention strategy to address unmet needs and move beyond a hospital- and MSM-centred model. A structural, coordinated and inclusive response is essential to expand PrEP uptake and ensure equitable protection for all populations at risk.</p>","PeriodicalId":201,"journal":{"name":"Journal of the International AIDS Society","volume":"29 5","pages":"e70118"},"PeriodicalIF":4.9000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13125949/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the International AIDS Society","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jia2.70118","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Pre-exposure prophylaxis (PrEP) represents a major advance in HIV prevention, but its rollout in France remains limited, particularly among women, migrants and socially vulnerable populations. Despite full reimbursement by the national health system, oral PrEP is still rarely prescribed outside hospital settings, hindered by organizational constraints, inaccurate medical perceptions and persistent access inequalities. In this paper, we discuss the current limits of PrEP implementation in France, identify structural and individual barriers to its uptake and highlight possible strategies to make HIV prevention more accessible for all vulnerable populations across the country.

Discussion: The goal of eliminating HIV transmission by 2030 in France continues to be jeopardized by insufficient PrEP coverage. The current prevention model remains overly hospital-centred and primarily focused on a group of men who have sex with men (MSM), which limits its broader impact. In addition to structural barriers, the insufficient diversity of prescribers and the lack of inclusive communication continue to reinforce inequalities in access. The arrival of long-acting injectable PrEP offers an important opportunity to ensure greater discretion and better adherence. However, its success will depend on expanding the range of authorized prescribers to include gynaecologists, general practitioners and family planning clinics, supported by specific training and outreach consultations. Equally critical is strengthening public awareness campaigns and extending them beyond MSM and urban centres such as Paris, to reach diverse populations across the country. Durable improvements in PrEP uptake and retention also depend on close collaboration with community-based organizations, building trust with marginalized populations and participatory approaches that actively listen to individuals' concerns and lived experiences.

Conclusions: France, which is lagging behind its objective of ending the HIV epidemic, has the opportunity to rethink its prevention strategy to address unmet needs and move beyond a hospital- and MSM-centred model. A structural, coordinated and inclusive response is essential to expand PrEP uptake and ensure equitable protection for all populations at risk.

朝着更容易获得和更具包容性的PrEP,打破法国艾滋病毒的恶性循环。
暴露前预防(PrEP)是艾滋病毒预防方面的一项重大进展,但其在法国的推广仍然有限,特别是在妇女、移民和社会弱势群体中。尽管国家卫生系统全额报销,但由于组织限制、不准确的医学观念和持续的获取不平等,口服PrEP在医院外仍然很少开处方。在本文中,我们讨论了目前在法国实施PrEP的限制,确定了其采用的结构性和个人障碍,并强调了使全国所有弱势群体更容易获得艾滋病毒预防的可能策略。讨论:法国到2030年消除艾滋病毒传播的目标继续因PrEP覆盖率不足而受到威胁。目前的预防模式仍然过于以医院为中心,主要集中于男男性行为者群体,这限制了其更广泛的影响。除了结构性障碍外,开处方者的多样性不足和缺乏包容性沟通继续加剧了获取方面的不平等。长效注射PrEP的出现提供了一个重要的机会,以确保更大的判断力和更好的依从性。然而,它的成功将取决于扩大授权开处方者的范围,包括妇科医生、全科医生和计划生育诊所,并辅以具体培训和外联咨询。同样重要的是加强公众意识运动,并将其扩展到男同性恋者和巴黎等城市中心以外,以覆盖全国各地的不同人群。在PrEP的吸收和保留方面的持久改善还取决于与社区组织的密切合作,与边缘化人群建立信任,以及积极听取个人关切和生活经验的参与性方法。结论:法国落后于其终止艾滋病毒流行的目标,现在有机会重新考虑其预防战略,以解决未满足的需求,并超越以医院和男男性行为者为中心的模式。结构性、协调和包容的应对措施对于扩大预防措施的采用和确保所有风险人群得到公平保护至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of the International AIDS Society
Journal of the International AIDS Society IMMUNOLOGY-INFECTIOUS DISEASES
CiteScore
8.60
自引率
10.00%
发文量
186
审稿时长
>12 weeks
期刊介绍: The Journal of the International AIDS Society (JIAS) is a peer-reviewed and Open Access journal for the generation and dissemination of evidence from a wide range of disciplines: basic and biomedical sciences; behavioural sciences; epidemiology; clinical sciences; health economics and health policy; operations research and implementation sciences; and social sciences and humanities. Submission of HIV research carried out in low- and middle-income countries is strongly encouraged.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书